SEC, CFTC End ‘Turf Wars’ with Historic Pact

SEC and CFTC end turf wars with coordinated oversight pact for crypto innovation.

  • The SEC and CFTC have signed an MOU to coordinate oversight and end decades of “regulatory turf wars.”
  • The agreement aims to provide clarity for crypto and other tech blurring jurisdictional lines.
  • The agencies will adopt a “minimum effective dose” regulatory strategy to foster innovation.
  • This move supports President Donald Trump‘s goal of making the US the “crypto capital of the world.”

On Wednesday, the Securities and Exchange Commission and the Commodity Futures Trading Commission signed a memorandum of understanding to better coordinate oversight of financial markets. The agencies declared it a “pivotal time” to regulate in harmony as new technologies like crypto challenge traditional monitoring.

- Advertisement -

According to the memorandum, new trading models and automated systems increasingly blur traditional jurisdictional lines. Consequently, the SEC and CFTC will aim to provide regulatory clarity built on technology-neutral rules. The memorandum of understanding they wrote states they will share information on issues of “common regulatory interest.”

In a separate statement, SEC chair Paul Atkins said the memo is the latest step toward repairing the relationship between the agencies. He noted, “For decades, regulatory turf wars, duplicative agency registrations, and different sets of regulations between the SEC and CFTC have stifled innovation and pushed market participants to other jurisdictions.”

Both agencies have made strides to deliver on President Donald Trump’s mission. They have established a crypto-specific task force and an advisory committee for emerging tech. The memo also states they strive to provide a “fit-for-purpose regulatory framework for crypto assets.”

The regulatory clarity will apply to market participants operating across securities and derivatives frameworks. Meanwhile, the two agencies plan to adopt a “minimum effective dose” strategy to foster innovation. This pharmacological term refers to the smallest dose producing the desired therapeutic benefit.

- Advertisement -

✅ Follow BITNEWSBOT on Telegram, Facebook, LinkedIn, X.com, and Google News for instant updates.

Previous Articles:

- Advertisement -

Latest News

AI Chatbots Found to Help Teens Plan Attacks: Study

Eight out of ten major AI chatbots readily assisted simulated teenagers in planning violent...

Ripple Plans $750M Buyback at $50B Valuation

Ripple Labs plans a $750 million share buyback with the tender offer running through...

Goldman Sees Extreme Rally Setup in US Stocks

Analysts at Goldman Sachs suggest hedge fund positioning has set up US equities for...

Ripple to Buy Back Shares at $50 Billion Valuation

Ripple has begun a share buyback program, offering up to $750 million for shares...

Strive buys Strategy’s STRC shares in circular $50M deal

Bitcoin treasury firm Strive purchased $50 million of rival Strategy's dividend-paying STRC stock in...

Must Read

17 Best Cryptocurrency Wallets

If you are looking for a list with the best cryptocurrency wallets, then you've landed on the right page. Cryptocurrency, as we all know,...